158 related articles for article (PubMed ID: 15099785)
1. Depo medroxyprogesterone acetate (DMPA) therapy for uterine myomata prior to surgery.
Johnson N; Fletcher H; Reid M
Int J Gynaecol Obstet; 2004 May; 85(2):174-6. PubMed ID: 15099785
[No Abstract] [Full Text] [Related]
2. Medical management of uterine fibroids with medroxyprogesterone acetate (Depo Provera): a pilot study.
Venkatachalam S; Bagratee JS; Moodley J
J Obstet Gynaecol; 2004 Oct; 24(7):798-800. PubMed ID: 15763792
[TBL] [Abstract][Full Text] [Related]
3. Corona stenting in a patient menorrhagia: use of a gonadotrophin releasing hormone agonist to facilitate anticoagulation.
Khurana C; Taylor P; de Belder MA
Int J Cardiol; 1998 Jan; 63(1):89-91. PubMed ID: 9482151
[TBL] [Abstract][Full Text] [Related]
4. Goserelin acetate 10.8 mg plus iron versus iron monotherapy prior to surgery in premenopausal women with iron-deficiency anemia due to uterine leiomyomas: results from a Phase III, randomized, multicenter, double-blind, controlled trial.
Muneyyirci-Delale O; Richard-Davis G; Morris T; Armstrong J
Clin Ther; 2007 Aug; 29(8):1682-91. PubMed ID: 17919549
[TBL] [Abstract][Full Text] [Related]
5. Prevention of severe menorrhagia in oncology patients with treatment-induced thrombocytopenia by luteinizing hormone-releasing hormone agonist and depo-medroxyprogesterone acetate.
Meirow D; Rabinovici J; Katz D; Or R; Shufaro Y; Ben-Yehuda D
Cancer; 2006 Oct; 107(7):1634-41. PubMed ID: 16944540
[TBL] [Abstract][Full Text] [Related]
6. Ulipristal acetate versus placebo for fibroid treatment before surgery.
Donnez J; Tatarchuk TF; Bouchard P; Puscasiu L; Zakharenko NF; Ivanova T; Ugocsai G; Mara M; Jilla MP; Bestel E; Terrill P; Osterloh I; Loumaye E;
N Engl J Med; 2012 Feb; 366(5):409-20. PubMed ID: 22296075
[TBL] [Abstract][Full Text] [Related]
7. Ulipristal acetate versus leuprolide acetate for uterine fibroids.
Donnez J; Tomaszewski J; Vázquez F; Bouchard P; Lemieszczuk B; Baró F; Nouri K; Selvaggi L; Sodowski K; Bestel E; Terrill P; Osterloh I; Loumaye E;
N Engl J Med; 2012 Feb; 366(5):421-32. PubMed ID: 22296076
[TBL] [Abstract][Full Text] [Related]
8. [Myomectomy performed after Zoladex preparation with subsequent repair of the uterine wall via a balloon catheter in the uterine cavity].
Nikolov A; Raĭcheva R; Maĭnkhard K
Akush Ginekol (Sofiia); 1998; 37(1):55-7. PubMed ID: 9770805
[No Abstract] [Full Text] [Related]
9. Levonorgestrel-releasing intrauterine device insertion ameliorates leiomyoma-dependent menorrhagia among women of reproductive age without a significant regression in the uterine and leiomyoma volumes.
Murat Naki M; Tekcan C; Ozcan N; Cebi M
Fertil Steril; 2010 Jun; 94(1):371-4. PubMed ID: 19896649
[TBL] [Abstract][Full Text] [Related]
10. [Medical treatment of the uterine miomas in perimenopausal patients].
Olvera-Maldonado AJ; Martínez-Uribe A; Rendón-Macías ME; Sangines-Martínez A
Ginecol Obstet Mex; 2015 Jan; 83(1):41-7. PubMed ID: 26016315
[TBL] [Abstract][Full Text] [Related]
11. Long-term treatment of uterine fibroids with ulipristal acetate ☆.
Donnez J; Vázquez F; Tomaszewski J; Nouri K; Bouchard P; Fauser BC; Barlow DH; Palacios S; Donnez O; Bestel E; Osterloh I; Loumaye E;
Fertil Steril; 2014 Jun; 101(6):1565-73.e1-18. PubMed ID: 24630081
[TBL] [Abstract][Full Text] [Related]
12. Prolapsed leiomyoma with severe haemorrhage after GnRH analogue therapy.
Kriplani A; Agarwal N; Parul D; Bhatla N; Saxena AK
J Obstet Gynaecol; 2002 Jul; 22(4):449-51. PubMed ID: 12521484
[No Abstract] [Full Text] [Related]
13. Goserelin (Zoladex) and the anaemic patient.
Vercellini P; Crosignani PG
Br J Obstet Gynaecol; 1994 May; 101 Suppl 10():33-7. PubMed ID: 8199103
[No Abstract] [Full Text] [Related]
14. Naproxen reduces idiopathic but not fibromyoma-induced menorrhagia.
Ylikorkala O; Pekonen F
Obstet Gynecol; 1986 Jul; 68(1):10-2. PubMed ID: 3523328
[TBL] [Abstract][Full Text] [Related]
15. Gonadotropin releasing hormone agonist treatment before hysterectomy for menorrhagia and uterine leiomyomas.
Vercellini P; Bocciolone L; Colombo A; Vendola N; Meschia M; Bolis G
Acta Obstet Gynecol Scand; 1993 Jul; 72(5):369-73. PubMed ID: 8392268
[TBL] [Abstract][Full Text] [Related]
16. The effects of hormone replacement therapy on uterine fibroids in postmenopausal women.
Sener AB; Seçkin NC; Ozmen S; Gökmen O; Doğu N; Ekici E
Fertil Steril; 1996 Feb; 65(2):354-7. PubMed ID: 8566261
[TBL] [Abstract][Full Text] [Related]
17. [The effects of menopausal replacement therapy in women with uterine myomas].
Orsini G; Pinto V; Di Biase S; D'Altorio C; Lanzilotti G
Minerva Ginecol; 1999 Nov; 51(11):421-5. PubMed ID: 10726441
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of uterine leiomyoma with depot leuprorelin acetate (Enantone-Gyn monthly depot). Effect on leiomyoma volume and operability. German Leuprorelin Study Group].
Stolz W; Pfützenreuter N
Zentralbl Gynakol; 1997; 119(10):468-75. PubMed ID: 9432825
[TBL] [Abstract][Full Text] [Related]
19. Zoladex (goserelin acetate) and the anemic patient: results of a multicenter fibroid study.
Benagiano G; Kivinen ST; Fadini R; Cronjé H; Klintorp S; van der Spuy ZM
Fertil Steril; 1996 Aug; 66(2):223-9. PubMed ID: 8690106
[TBL] [Abstract][Full Text] [Related]
20. [GnRH analogues and myomas: which strategy?].
Cohen J
Gynecol Obstet Fertil; 2006 May; 34(5):462. PubMed ID: 16630742
[No Abstract] [Full Text] [Related]
[Next] [New Search]